TrialDiabetes2024

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.

Lixin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.